Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-005685-12Phase 2Completed
Phase 2, randomised, double-blind trial of estradiol valerate and progesterone (3 arms), sponsored by Clinical Division of Biological Psychiatry, Medical University of Vienna. Primary endpoint: Change in cerebral serotonin-1A receptor binding potential. Started Jul 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-005685-12.